ADXN — Addex Therapeutics Ltd
On NASDAQ, Addex Therapeutics Ltd trades as ADXN.
Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
Searching for the Addex Therapeutics Ltd share price, or whether to buy ADXN? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.
VAQO runs a statistical model over ADXN that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.
What ADXN is
Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland.…
Addex Therapeutics Ltd is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ADXN size and valuation
At roughly $5.6M, ADXN is a micro-cap.
Earnings per share are negative at -7.56, so there is no meaningful price-to-earnings multiple to quote.
Beta is 1.96: historically it has moved more than the market.
ADXN over the past year
Over the past year ADXN has traded between $2.56 and $11.97, and the current price sits at 4% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $4.35 against a 200-day average of $6.28 — the shorter average sits below the longer one, usually read as a downtrend.
The published analyst target is $30.00, 930.9% above it. A target is an aggregate of opinions, not a measurement.
How Addex Therapeutics Ltd (ADXN) is trading
Addex Therapeutics Ltd (ADXN) is down 2.02% at $2.91 — a more volatile session than average.
The session ranged from $2.88 to $3.23 — 12.0% of the share price — and the current price sits at 9% of that range.
It opened at 100% of the daily range and finished at 9% of it — an intraday reversal in the sellers' favour.
It opened at $3.23 against a previous close of $2.97 — an opening gap of +8.8%, which almost always comes from information released outside trading hours.
Volume ran near 7.3K shares, about $21.1K of stock changing hands.
Traded alongside ADXN
Names traded alongside ADXN in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ADXN
Two statistical models run over ADXN inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Key facts
- Symbol: ADXN
- Name: Addex Therapeutics Ltd
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ADXN — frequently asked questions
What is the market cap of ADXN?
Addex Therapeutics Ltd has a market capitalisation of roughly $5.6M.
What is the 52-week range for ADXN?
ADXN has traded between $2.56 and $11.97 over the past year, with the current price at 4% of that range.
How much does ADXN stock cost today?
Addex Therapeutics Ltd (ADXN) trades at $2.91, a change of -2.02% in the latest session.
Is ADXN up or down today?
ADXN is down 2.02% in the latest session, at $2.91.
What is the daily trading range for ADXN?
ADXN traded between $2.88 and $3.23 in the latest session, and currently trades at $2.91.
What is the trading volume for ADXN?
ADXN traded roughly 7.3K shares in the latest session.
Which exchange is ADXN listed on?
ADXN is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ADXN stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ADXN figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Others in HEALTHCARE
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08